Bacterial and Chemical Carcinogens in Gastric Oncogenesis
胃肿瘤发生中的细菌和化学致癌物
基本信息
- 批准号:8271317
- 负责人:
- 金额:$ 32.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidityAdherenceAfrica South of the SaharaAngiodysplasiaAnimalsAntioxidantsApoptosisAttentionBiopsyCancer EtiologyCarcinogensCessation of lifeChemopreventive AgentClinical ResearchComplexCountryDNA Repair GeneDietDietary ComponentDietary FactorsDietary NitrosamineDiseaseEarly DiagnosisEmployee StrikesEpidemiologic StudiesEpithelialEpithelial CellsEquilibriumGastric mucosaGastritisGene ExpressionGenesGenomeGenotypeGoalsGrantHarvestHealthHelicobacter InfectionsHelicobacter pyloriHistologyHistopathologyHumanIL8 geneImmune responseIn Situ HybridizationIn VitroIncidenceIndividualInfectionInflammationInflammatoryInflammatory ResponseIntakeIntraepithelial NeoplasiaIsoflavonesJapanLesionLifeMacaca mulattaMicroscopicModelingMolecularMolecular ProfilingMonkeysMorbidity - disease rateNeoplasmsNeoplastic Cell TransformationNutrientOralOral AdministrationOutputPathogenesisPatientsPeptic UlcerPeripheralPeristalsisPersonsPhenotypePhytoestrogensPlacebosPlayPopulationPremalignantPrimatesPrincipal InvestigatorProductionProspective StudiesRegulatory T-LymphocyteRelative (related person)ResearchRetrospective StudiesReverse Transcriptase Polymerase Chain ReactionRiskRoleStagingStomachStomach CarcinomaSubgroupSurvival RateT-LymphocyteTestingTimeTumor Suppressor GenesVirulenceVirulentbasecarcinogenesischemical carcinogencytokinedietary antioxidantin vivomortalityneoplasticnovelpreventprogramsprospectiverepairedresponsestomach endoscopytumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Gastric Carcinoma (GC) is the second leading cause of cancer death worldwide, but its incidence is highly variable among different countries and populations. Whether GC occurs or not depends on a complex equilibrium between inflammation resulting from gastric bacterial flora (especially Helicobacter pylori), and intake of carcinogenic and protective nutrients. H. pylori persists in the gastric mucosa of >50% of humans worldwide for the life of the host, despite intense immune and inflammatory responses, gastric acidity, peristalsis, and epithelial turnover. We receltly demonstrated that H. pylori infection alone caused only a persistent inflammatory response and that a dietary carcinogen alone caused only angiodysplasia. In contrast, the association of the carcinogen and H. pylori infection for three years induced precancerous lesions that were replaced at 5-year by intraepithelial neoplasia in half of the animals. Array, real- time RT-PCR, and in situ hybridization analysis of gastric biopsies demonstrated molecular signatures that were specific to each of the monkey subgroups, including the three animals with intraepithelial neoplasia. Progress to date illustrates the complexity of the co-carcinogenenic effects of bacterial and dietary factors and the following hypotheses:: (1) H. pylori up-regulates pro-inflammatory genes and down-regulates DNA repair genes and tumor suppressor genes (TSG); the resulting weakening of normal repair mechanisms of epithelial cells may potentiate the effects of dietary carcinogens and be counteracted by protective dietary phytoestrogens; (2) an imbalance between the functions of effector and regulatory T cells may promote carcinogenesis; and (3) The gastric milieu promotes alterations of the H. pylori genome and modifies its virulence. The rhesus monkey model is particularly well adapted to test these hypotheses and to fulfill the following specific aims: (1) to characterize the effect of the bacterial carcinogen H. pylori, of a dietary procarcinogen and of protective nutrients on gastric mucosa at the macroscopic, microscopic and molecular level; (2) to study the gastric mucosal cellular immune response in response to long term H. pylori infection and dietary factors; and (3) to explore the effect of diet and of the host's responses on H. pylori genome. Monkeys with and without H. pylori infection and/or administration of a dietary carcinogen will be exposed to an isoflavones-depleted diet and the gastric mucosa will be studied for precancerous and neoplasitc transformation This prospective study of histological and molecular effects of diet and bacterial carcinogens will provide novel and useful information regarding the early and late stages of carcinogenesis. PUBLIC HEALTH RELEVANCE: Gastric Carcinoma (GC) is the second leading cause of cancer death worldwide. Because survival at 5-year is very low, there is a need for a better understanding of the pathogenesis of the disease The proposed studies will permit a prospective analysis of the histological and molecular effects of dietary components and bacterial carcinogens during the early and late stages of carcinogenesis in a primate model.
描述(申请人提供):胃癌(GC)是全球第二大癌症死亡原因,但其发病率在不同国家和人群中差异很大。GC的发生取决于胃菌群(尤其是幽门螺杆菌)引起的炎症与致癌和保护性营养物质的摄入之间的复杂平衡。幽门螺杆菌在全世界50%的人的胃粘膜中持续存在,尽管有强烈的免疫和炎症反应,胃酸,蠕动和上皮细胞的更替。我们最近证明,单独感染幽门螺杆菌只会引起持续性的炎症反应,而饮食致癌物质只会引起血管发育不良。相反,致癌物质和幽门螺杆菌感染相关联三年后,一半动物的癌前病变在五年后被上皮内瘤变取代。对胃活检组织的阵列、实时RT-PCR和原位杂交分析显示了每个猴子亚组特有的分子特征,包括三种患有上皮内瘤变的动物。迄今的研究进展说明了细菌和饮食因素以及下列假设共同致癌作用的复杂性:(1)幽门螺杆菌上调促炎基因,下调DNA修复基因和肿瘤抑制基因(TSG);由此导致的上皮细胞正常修复机制的减弱可能会增强饮食致癌物的影响,并可被保护性饮食植物雌激素所抵消;(2)效应器和调节性T细胞功能之间的失衡可能促进癌症的发生;以及(3)胃环境促进幽门螺杆菌基因组的改变并改变其毒力。恒河猴模型特别适合于检验这些假说,并实现以下特定目的:(1)在宏观、微观和分子水平上表征致癌物幽门螺杆菌、饮食前致癌物和保护性营养素对胃粘膜的影响;(2)研究胃粘膜对幽门螺杆菌长期感染和饮食因素的细胞免疫反应;以及(3)探讨饮食和宿主反应对幽门螺杆菌基因组的影响。无论有没有幽门螺杆菌感染和/或饮食致癌物,猴子将暴露在异黄酮类耗竭的饮食中,胃粘膜将被研究癌前病变和肿瘤转化。这项关于饮食和细菌致癌物的组织和分子效应的前瞻性研究将为致癌的早期和晚期提供新的有用的信息。公共卫生相关性:胃癌(GC)是全球癌症死亡的第二大原因。由于5年存活率很低,有必要更好地了解该病的发病机制。拟议的研究将允许在灵长类动物模型中对饮食成分和细菌致癌物在致癌早期和晚期的组织和分子影响进行前瞻性分析。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans.
SABA是幽门螺杆菌血凝素的H.
- DOI:10.1371/journal.ppat.0020110
- 发表时间:2006-10
- 期刊:
- 影响因子:6.7
- 作者:Aspholm, Marina;Olfat, Farzad O.;Norden, Jenny;Sonden, Berit;Lundberg, Carina;Sjostrom, Rolf;Altraja, Siiri;Odenbreit, Stefan;Haas, Rainer;Wadstrom, Torkel;Engstrand, Lars;Semino-Mora, Cristina;Liu, Hui;Dubois, Andre;Teneberg, Susann;Arnqvist, Anna;Boren, Thomas
- 通讯作者:Boren, Thomas
Mechanism of H. pylori intracellular entry: an in vitro study.
- DOI:10.3389/fcimb.2012.00013
- 发表时间:2012
- 期刊:
- 影响因子:5.7
- 作者:Liu H;Semino-Mora C;Dubois A
- 通讯作者:Dubois A
Development of a noninvasive method for detecting and monitoring the time course of Helicobacter pylori infection.
开发一种非侵入性方法来检测和监测幽门螺杆菌感染的时间过程。
- DOI:10.1128/iai.72.9.5358-5364.2004
- 发表时间:2004
- 期刊:
- 影响因子:3.1
- 作者:Nyan,DougbehC;Welch,AnthonyR;Dubois,Andre;ColemanJr,WilliamG
- 通讯作者:ColemanJr,WilliamG
In situ expression of cagA and risk of gastroduodenal disease in Helicobacter pylori-infected children.
幽门螺杆菌感染儿童中 cagA 的原位表达与胃十二指肠疾病的风险。
- DOI:10.1097/mpg.0b013e3181bab326
- 发表时间:2010
- 期刊:
- 影响因子:2.9
- 作者:Rick,JamesR;Goldman,Matthew;Semino-Mora,Cristina;Liu,Hui;Olsen,Cara;Rueda-Pedraza,Eugenia;Sullivan,Carolyn;Dubois,Andre
- 通讯作者:Dubois,Andre
Specific and sensitive detection of H. pylori in biological specimens by real-time RT-PCR and in situ hybridization.
通过实时 RT-PCR 和原位杂交特异性、灵敏地检测生物样本中的幽门螺杆菌。
- DOI:10.1371/journal.pone.0002689
- 发表时间:2008-07-16
- 期刊:
- 影响因子:3.7
- 作者:Liu H;Rahman A;Semino-Mora C;Doi SQ;Dubois A
- 通讯作者:Dubois A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D. SCOTT MERRELL其他文献
D. SCOTT MERRELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D. SCOTT MERRELL', 18)}}的其他基金
Contribution of Helicobacter pylori HomA and HomB to colonization and disease
幽门螺杆菌 HomA 和 HomB 对定植和疾病的贡献
- 批准号:
10301421 - 财政年份:2021
- 资助金额:
$ 32.3万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Fellowship Programs